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Abstract
We consider the problem of sequential multiple
hypothesis testing with nontrivial data collection
cost. This problem appears, for example, when
conducting biological experiments to identify differentially expressed genes in a disease process.
This work builds on the generalized α-investing
framework that enables control of the false discovery rate in a sequential testing setting. We make a
theoretical analysis of the long term asymptotic
behavior of α-wealth which motivates a consideration of sample size in the α-investing decision
rule. Using the game theoretic principle of indifference, we construct a decision rule that optimizes the expected return (ERO) of α-wealth and
provides an optimal sample size for the test. We
show empirical results that a cost-aware ERO decision rule correctly rejects more false null hypotheses than other methods. We extend cost-aware
ERO investing to finite-horizon testing which enables the decision rule to hedge against the risk
of unproductive tests. Finally, empirical tests on
a real data set from a biological experiment show
that cost-aware ERO produces actionable decisions as to which tests to conduct and if so at
what sample size.

1

INTRODUCTION

Machine learning systems are increasingly used to make
decisions in uncertain environments. Decision-making can
be viewed in the framework of hypothesis testing in that
a decision is made as the result of a rejection of the null
hypothesis (Arrow et al., 1949; Dickey and Lientz, 1970;
Blackwell and Girshick, 1979; Verdinelli and Wasserman,
1995; Parmigiani and Inoue, 2009; Berger, 2013). When
multiple hypotheses are under consideration, a false discovery rate (FDR) control procedure provides a way to control
the rate of erroneous rejections in a batch of hypotheses
for small-scale data sets (Benjamini and Hochberg, 1995;
Storey, 2002; Storey et al., 2004; Benjamini et al., 2006;
Zeisel et al., 2011; Liang and Nettleton, 2012). However,
these procedures typically require the test statistics of all
of the hypotheses under consideration so that the p-values
may be sorted and a set of hypotheses may be selected for
rejection. In many modern problems the test statistics for
all the hypotheses may not be known simultaneously and
standard FDR procedures do not work.
Online FDR methods have recently been developed to address the need for FDR control procedures that maintain
control for a sequence of tests when the test statistics are
not all known at one time. (Tukey and Braun, 1994) proposed the idea that one starts with a fixed amount “α-wealth”
and for each hypothesis under consideration, the researcher
may choose to spend some of that wealth until it is all gone.
(Foster and Stine, 2008) extended α-spending by allowing
some return on the expenditure of α-wealth if the hypothesis
is successfully rejected. (Aharoni and Rosset, 2014) introduced generalized α-investing and provided a deterministic
decision rule to optimally set the α-level for each test given
the history of test outcomes. A full review of related work
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is in Section 1.1.
Contributions. We extend generalized α-investing to address the problem of online FDR control where the cost of
data is not negligible. Our specific contributions are:
• a theoretical analysis of the long term asymptotic behavior of α-wealth in an α-investing procedure,
• a generalized α-investing procedure for sequential testing that simultaneously optimizes sample size and αlevel using the game-theoretic indifference principle,
• a non-myopic α-investing procedure that maximizes
the expected reward over a finite horizon of tests.
1.1

Related Work

Tukey proposed the notion of α-wealth to control the familywise error rate for a sequence of tests (Tukey, 1991; Tukey
and Braun, 1994). The Foster (Foster and Stine, 2008)
α-investing procedure controls the marginal FDR for any
stopping time in the testing sequence. (Aharoni and Rosset, 2014) introduced generalized α-investing and provided
a deterministic decision rule to maximize the expected reward for the next test in the sequence. Recently, there has
been much work on online FDR control in the context of
A/B testing, directed acyclic graphs and quality-preserving
databases (Yang et al., 2017; Ramdas et al., 2019). (Javanmard and Montanari, 2018) first proved that generalized
α-investing controls FDR, not only mFDR under an online setting with an algorithm called LORD. (Ramdas et al.,
2017) proposed the LORD++ to improve the existing LORD.
Recent work leverages contextual information in the data to
improve the statistical power while controlling FDR offline
(Xia et al., 2017) and online (Chen and Kasiviswanathan,
2020). (Ramdas et al., 2018) proposed SAFFRON, which
also belongs to the α-investing framework but adaptively
estimate the proportion of the true nulls. All the aforementioned methods are synchronous, which means that each
test can only start once the previous test has finished. (Zrnic et al., 2021) extended α-investing methods to an asynchronous testing where tests are allowed to overlap in time.
These state-of-the-art online FDR control α-investing methods do not address the needs for testing when the cost of
data is not negligible. So, we propose a novel α-investing
method for a setting that takes into account the cost of data
sample collection, the sample size choice, and prior beliefs
about the probability of rejection.
Section 2 is a technical background of generalized αinvesting. Section 3 contains a theoretical analysis of the
long term asymptotic behavior of the α-wealth. Section 4
presents a cost-aware generalized α-investing decision rule
based on the game-theoretic principle of indifference. Section 5 presents empirical experiments that show that the
cost-aware optimal decision rule improves upon existing
procedures when data collection costs are nontrivial. Sec-

tion 6 presents an analysis of a real data set from a gene
expression study that shows cost-aware α-investing aligns
with the overall objectives of the application setting. Finally,
Section 7 describes limitations and future work.

2

BACKGROUND ON GENERALIZED
α-INVESTING

Following (Foster and Stine, 2008), we have available m
null hypotheses, H1 , . . . , Hm where Hj ⊂ Θj . The random variable Rj ∈ {0, 1} is an indicator of whether Hj is
rejected regardless of whether the null is true or not. The
random variable Vj ∈ {0, 1} indicates whether the test Hj
is both true P
and rejected. These variables
Pm are aggregated
m
as R(m) = j=1 Rj and V (m) = j=1 Vj . With these
definitions, the FDR (Benjamini and Hochberg, 1995) is


V (m)
FDR(m) = Pθ (R(m) > 0) Eθ
| R(m) > 0 ,
R(m)
and the marginal false discovery rate is
mFDRη (m) =

Eθ [V (m)]
.
Eθ [R(m) + η]

Setting η = 1 − α provides weak control over the familywise error rate at level α.
(Aharoni and Rosset, 2014) makes two assumptions in their
development of generalized α-investing:
∀θj ∈ Hj : Pθj (Rj |Rj−1 , . . . , R1 ) ≤

αj ,

(1)

∀θj 6∈ Hj : Pθj (Rj |Rj−1 , . . . , R1 ) ≤

ρj ,

(2)

where
ρj =

sup
θj ∈Θj −Hj

Pθj (Rj = 1).

(3)

Assumption 1 constrains the false positive rate to the level of
the test and Assumption 2 puts an upper bound of ρj on the
power of the test. A pool of α-wealth, Wα (j), is available
to spend on the j-th hypothesis. The α-wealth is updated
according to the following equations:
Wα (0)

= αη,

Wα (j)

=

Wα (j − 1) − ϕj + Rj ψj .

(4)
(5)

A deterministic function IWα (0) is an α-investing rule that
determines: the cost of conducting the j-th hypothesis test,
ϕj ; the reward for a successful rejection, ψj ; and the level
of the test, αj :
(ϕj , αj , ψj ) = IWα (0) ({R1 , . . . , Rj−1 }).

(6)

The α-investing rule depends only on the outcomes of the
previous hypothesis tests. The Foster-Stine ante depends
hyperbolically on the level of the test ϕj = αj /(1 − αj ).
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Generalized α-investing can be viewed in a game-theoretic
framework where the outcome of the test (reject or fail-toreject) is random and the procedure provides the optimal
amount of “ante” to offer to play and “payoff” to demand
should the test successfully reject. We make use of this game
theoretic interpretation in our contributions in Section 4.

trade-off can be computed between more samples with a
higher variance technology, versus fewer samples with a
lower variance technology. For the remainder, we assume
σj is fixed and known. We implemented an exact form of
ERO α-investing for Neyman-Pearson testing problems by
solving the following nonlinear optimization problem:

(Aharoni and Rosset, 2014) derives a linear constraint on the
reward ψj to ensure that, for a given (ϕj , αj ), the marginal
FDR is controlled at a level α by ensuring the sequence
A(j) = αRj − Vj + αη − Wα (j) is a submartingale with
respect to Rj ,


ϕj
ϕj
ψj ≤ min
+ α,
+α−1 .
(7)
ρj
αj

max
αj , ψj
s.t.

Maximizing the expected reward of the next hypothesis test,
E(Rj )ψj , leads to the following equality
ϕj
ϕj
=
− 1.
ρj
αj

(8)

Note that this equality selects the point of intersection of
the two parts of the constraint in (7). Expected Reward Optimum (ERO) α-investing provides two equations for three
unknowns in the deterministic decision rule. (Aharoni and
Rosset, 2014) addresses this indeterminacy by considering
three allocation schemes for ϕj : constant, relative, and relative200 and suggest that the investigator can explore various
options and set ϕj on their own. Further details on these
schemes are given in Section 5.
Since the dominant paradigm in testing of biological hypotheses is a bounded finite range for Θj , for the remainder
we assume Θj = [0, θ̄j ] for some upper bound, θ̄j , and
Hj = {0}. This scenario may be viewed as a test that the
expression for gene j is differentially increased in an experimental condition compared to a control. We consider
a simple z-test here for concreteness.
The power of
 a one
0 −µ1 )
√
sided z-test is (1 − β) := 1 − Φ z1−α + (µσ/
where
n

Eθ (Rj )ψj
ϕj
+ α,
ρj
ϕj
+ α − 1,
ψj ≤
αj
ϕj
ϕj
=
− 1,
ρj
αj

ρj = 1 − Φ z1−αj −

(10a)

ψj ≤

(10b)
(10c)
(10d)
θ̄j
√
σj / nj


(10e)

Constraints 10b and 10c correspond to (7) which controls
the mFDR level, and constraint 10d ensures the maximal
expected reward for the j-th test. The optimal ERO still
depends on an external choice of the sample size nj , and
the cost of the test ϕj .

3

LONG-TERM α-WEALTH

Since the levels of future tests depend on the amount of αwealth available at the time of the tests, a theoretical consideration in generalized α-investing is whether the long-term
α-wealth is submartingale or supermartingale (stochastically non-decreasing or stochastically non-increasing) for a
given decision-rule. Here we outline two scenarios where
the long-term α-wealth can be either submartingale or supermartingale.
In order to state the theorems regarding the α-wealth sequence, we require a lemma bounding α-wealth as a function of the prior probability of the null hypothesis.

z1−α = Φ−1 (1 − α) is the z-score corresponding to level
α, µ0 is the expected value of the simple null hypothesis, µ1
is the expected value of the simple alternative hypothesis, σ
is the standard deviation of the measurements, and n is the
sample size.

Lemma 1. Given an αj -level for the j-th hypothesis test
from rule I(R1 , . . . Rj−1 ), the expected value of α-wealth
for Foster-Stine α-investing is

Using Equation (3), the best power under the previously
defined Θj is


θ̄j
.
(9)
ρj = 1 − Φ z1−αj −
√
σj / nj



(11)
αj
αj
−
+ [ρj − (ρj − αj )qj ] α +
,
1 − αj
1 − αj

The best power depends on: (1) the level of the test, αj , (2)
the scale of the bound on the alternative, θ̄j , (3) the sample
size, nj , and the measurement standard deviation, σj . One
may compare multiple measurement technologies based on
their precision by exploring the effect of changing σj — for
example, for a fixed budget and all other things equal, a

Ej−1 [Wj ] ≤

where Ej−1 [Wj ] = E [W (j) − W (j − 1)|W (j − 1)], and
qj = Pr[θj ∈ Hj ], the prior probability (belief) that the
j-th null hypothesis is true. In the case of a simple null and
alternative Θj = {0, θ̄j }, the bound is tight.
It is important to note that while αj is marginally random
because it depends on the sequence of rejections up until j,
conditional on Wα (j − 1), it is deterministic and given by
the decision rule I.
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Theorem 1 (Submartingale). Given a simple null and alternative Θj = {0, θ̄j }, {W (j) : j ∈ N} is submartingale
(stochastically non-decreasing) if
ρj ≥

1
αj /(1 − αj )
.
α + αj /(1 − αj ) 1 − qj

(12)

Theorem 1 shows that one will be able to conduct an infinite
number of tests in the long-term if the power is close to one
or the prior probability of the null is close to zero. This
scenario may occur when the hypothesis stream contains
a large proportion of true alternative hypotheses, or if the
sample sizes of the individual tests are large.
Theorem 2 (Supermartingale). For any null and alternative
hypothesis, {W (j) : j ∈ N} is supermartingale (stochastically non-increasing) if

ρj ≤

αj /(1 − αj )
− qj
α + αj /(1 − αj )



1
.
1 − qj

(13)

Theorem 2 shows that the generalized α-investing testing
procedure will end in a finite number of steps if the power
of the test is close to zero or the prior probability of the null
hypothesis is close to one. This scenario may occur when
the hypothesis stream is made up of a large proportion of
true null hypotheses, or if the sample sizes used for each
test results in an under powered test.
These theorems provide general insights for understanding
when the α-wealth can be expected to be (stochastically)
non-decreasing or non-increasing. The non-decreasing sequences require that ρj ↑ 1 for a fixed
√ θ̄j which, in the
case of a Gaussian, would require σj / n → 0 or n → ∞.
So, the α-wealth grows unbounded if the sample size is
unbounded. This theory in combination with the premise of
non-trivial experiment costs motivates the need for methods
for cost-aware α-investing when the sample size is not fixed.
We formally state the proofs of these lemmas and theorems
in Appendix A.

4

COST-AWARE GENERALIZED
α-INVESTING

Our development in this section derives from two key differences in assumptions compared to previous work. Here
we make the following assumptions: (1) the per sample
monetary cost to conduct hypothesis tests is not trivial, and
(2) the α-cost of a hypothesis test, ϕj , should account for
the a-priori probability that the null hypothesis is true as
well as the pattern of previous rejections.
Cost-aware ERO α-investing. The generalized αinvesting decision rule, (6), is augmented to include a notion
of dollar-wealth W$ (j) available for expenditure to collect

data to test the j-th hypothesis
(ϕj , αj , ψj , nj ) = I(Wα (0), W$ (0))({R1 , . . . , Rj−1 }),
(14)
where nj is the sample size allocated for testing of the j-th
hypothesis. A natural update plan for the dollar-wealth is
W$ (0)

= B

W$ (j)

=

W$ (j − 1) − cj nj ,

(15)
(16)

where cj is the per-sample cost for data to test the j-th
hypothesis, and B is the initial dollar-wealth. Allowing
the cost to vary with the hypothesis test enables one to
model different experimental methods and cost inflation
for long-term experimental plans. The augmented optimization problem is identical to Problem 10 with objective
maxϕj ,αj ,ψj ,nj Eθ (Rj )ψj and constraint nj cj ≤ W$ (j).
Game Theoretic Formulation. The resulting optimization problem has an infinite number of solutions because ϕj
is not constrained. Thus the problem does not yet constitute
a self-contained decision rule for (14). Indeed, (Aharoni
and Rosset, 2014), throughout, suggest a scenario where
ϕj is chosen by the investigator and the level and reward
are given by the decision rule. To develop a self-contained
decision rule, we cast the objective function in a Bayesian
framework by allowing for the specification of the prior
probability of the null hypothesis,
Eθ [Rj ]ψj = [αj qj + ρj (1 − qj )] ψj ,
where qj = Pr[θj ∈ Hj ]. Suppose that we have a zero-sum
game involving two players: the investigator (Player I) and
nature (Player II). Nature, independent of the investigator,
chooses to hide θj ∈ Hj with probability qj and θj 6∈
Hj otherwise. The investigator has the choice between
two pure strategies: to conduct a test or to not conduct
a test. If the investigator chooses not to conduct a test,
there is no cost (ϕj = 0) and there is no reward (ψj = 0)
regardless of what nature has chosen. So, the α-value of
not conducting a test is zero. If the investigator chooses
to conduct a test, the value of the game is −ϕj + ψj with
probability αj qj + ρj (1 − qj ) (the investigator rejects), and
−ϕj with probability (1 − αj )qj + (1 − ρj )(1 − qj ) (the
investigator fails to reject). The investigator selects as the
amount they are willing to pay to conduct the experiment,
ϕj , an amount such that they are indifferent as to whether
or not to conduct the experiment,
(−ϕj + ψj ) · [αj qj + ρj (1 − qj )]+
(−ϕj ) · [(1 − αj )qj + (1 − ρj )(1 − qj )] = 0

(17)

The value of this two-player game is in fact the change in αwealth, analyzed in section 3. The principle of indifference
selects a rule that strikes a balance between the settings
proposed in Theorem 1 and Theorem 2.
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Cost-aware ERO Decision Rule. Incorporating this indifference constraint and the cost of the experiment into the
ERO problem yields a self-contained decision rule in the
form of (14),
max
ϕj , αj , ψj , nj
s.t.

Eθ (Rj )ψj
ϕj
+ α,
ρj
ϕj
ψj ≤
+ α − 1,
αj
ϕj
ϕj
=
− 1,
ρj
αj

ρj = 1 − Φ z1−αj −

(18a)

ψj ≤

(18b)
(18c)

θ̄j
√
σj / nj

form of the game between Nature, who hides θj in the null
or alternative hypothesis region, and the investigator, who
seeks to find θj and gain the reward for doing so, is shown
in Appendix G. We note that sequential two-step cost-aware
ERO investing is a different problem than batch ERO investing because two-step investing accounts for the change in
(α, $)-wealth after each step while batch cost-aware ERO
only received the payoff at the conclusion of all of the tests
in the batch.
The two-step objective function is

(18d)

,

E(Rj ψj + Rj+1 ψj+1 ) = E(Rj )ψj +
ψj+1 [P (Rj = 0)E(Rj+1 |Rj = 0)+

(19)

P (Rj = 1)E(Rj+1 |Rj = 1)]

(18e)
ϕj ≤ Wα (j − 1),
nj cj ≤ W$ (j),
0 = E [∆Wα ] ,

(18f)
(18g)
(18h)

Constraints (18b) and (18c) ensure control over the mFDR.
Constraint (18e) connects the level, power, and sample size
of the test. Constraints (18f) and (18g) ensure the existing
(α, $)-wealth is not exceeded. Constraint (18h) ensures the
minimax solution to the game. Written out explicitly,
E [∆Wα ] = (−ϕj + ψj ) Pr[Rj = 1] + (−ϕj ) Pr[Rj = 0],
Pr[Rj = 1] = αj qj + ρj (1 − qj ),
Pr[Rj = 0] = (1 − αj )qj + (1 − ρj )(1 − qj ).
A pseudo-code algorithm of the full cost-aware ERO method
and further extensions to cost-aware ERO are described in
Appendix C.
Constraint (18h) sets the expected change in α-wealth equal
to zero. This enforces that Wα (j) is martingale. Allowing
Wα (j) to be submartingale, as per Theorem 1, can lead to a
situation where hypotheses are tested at high α-levels due
to the accumulated Wα from previous rejections. This is
referred to as piggybacking in the literature when such accumulated wealth leads to poor decisions (Ramdas et al., 2017).
On the other hand, allowing Wα (j) to be supermartingale,
as per Theorem 2, causes the testing to end, and is referred
to as α-death in the literature. Using a game-theoretic formulation allows us to propose an expected-reward optimal
procedure which considers preventing α-death and piggybacking.
Finite horizon cost-aware ERO α-investing. The standard ERO framework optimizes only the one-step expected
return, Eθ (Rj )ψj . But, when tests are expensive, it is logical to consider the expected return after two (or more) tests.
We consider qj to be known, and extend the game theoretic
framework to a finite horizon of decisions. The extensive

with constraints a-f from Problem 18 remaining for steps
j and j + 1. Applying the principle of indifference to this
game results in a system of equations (Appendix G) that
form constraints in the ERO optimization problem.

5

SYNTHETIC DATA EXPERIMENTS

Experimental Settings To compare our method with stateof-the-art related methods, we generate synthetic data as
described in (Aharoni and Rosset, 2014). The synthetic
data is composed of m = 1000 possible hypothesis tests.
For the j-th test, the true state of θj is set to the null value
of 0 with probability 0.9 and otherwise set to 2. A set
nj
of nj = 1000 potential samples (xji )i=1
were generated
i.i.d from a N (θj , 1) distribution. For each hypothesis test,
p Pn∗j
the z-score was computed as zj = n∗j i=1
xji , where
n∗j is described in the table and the one-sided p-value is
computed. The methods were tested on 10, 000 realizations
of this simulation data generation mechanism. Pseudo-code,
as well as other implementation details, for this simulation
up can be found in Appendix B.
5.1

Comparison to state-of-the-art methods

Table 1 compares our method, cost-aware ERO, with related state-of-the-art α-investing methods including: αspending (Tukey and Braun, 1994), α-investing (Foster
and Stine, 2008), α-rewards (Aharoni and Rosset, 2014),
ERO-investing (Aharoni and Rosset, 2014), LORD (Javanmard and Montanari, 2018; Ramdas et al., 2017), and SAFFRON (Ramdas et al., 2018). The table is indexed by the allocation scheme (Scheme), and the reward method (Method).
The allocation scheme determines the value of ϕj at each
step. The constant scheme simply allocates,

ϕj = min


1
Wα (0), Wα (j − 1) ,
10

Cost-aware Generalized α-investing for Multiple Hypothesis Testing

Tests

True Rejects

False Rejects

mFDR

α-spending
α-investing
α-rewards k = 1
α-rewards k = 1.1
ERO investing

10.0
16.0
14.7
16.4
18.3

0.28
0.44
0.41
0.44
0.50

0.04
0.06
0.06
0.06
0.07

0.032
0.044
0.043
0.043
0.048

relative

α-spending
α-investing
α-rewards k = 1
α-rewards k = 1.1
ERO investing

66.0
81.5
80.7
80.4
82.7

0.55
0.87
0.85
0.81
0.92

0.04
0.08
0.08
0.07
0.10

0.026
0.044
0.042
0.039
0.050

other

LORD++
LORD1
LORD2
LORD3
SAFFRON

934.9
1000.0
1000.0
1000.0
1000.0

2.59
1.45
2.00
2.72
1.64

0.06
0.03
0.06
0.07
0.09

0.015
0.014
0.020
0.020
0.035

cost-aware
cost-aware
cost-aware
cost-aware

ERO nj = 1
ERO nj ≤ 10
ERO nj ≤ 100
ERO n∗j

365.6
39.8
34.3
34.2

4.16
3.99
3.43
3.42

0.22
0.21
0.17
0.17

0.041
0.040
0.038
0.038

Scheme

Method

constant

Table 1: Comparison of cost-aware α-investing with state-of-the-art sequential hypothesis testing methods. Values for Tests,
True Rejects and False Rejects are the average across 10,000 iterations, and these estimates are used for mFDR.
for each test, the relative scheme allocates an amount that is
proportional to the remaining α-wealth,
ϕj =

1
Wα (j − 1)
10

and continues until Wα (j) < (1/1000)Wα (0). The relative 200 scheme follows the same proportional steps as the
relative, but always performs 200 tests (Aharoni and Rosset, 2014). The results from our implementation of these
methods matches or exceeds previously reported results.
ERO investing yields more true rejects than α-spending, αinvesting, and both α-rewards methods. The LORD variants
and SAFFRON perform nearly the maximum number of
tests while maintaining control of the mFDR. For the use
scenarios considered in the LORD and SAFFRON papers
(large-scale A/B testing), this is optimal — tests are nearly
free and the goal is to be able to keep testing while maintaining mFDR control. The cost-aware ERO setting is different
and more applicable to biological experiments where one
aims to maximize a limited budget of tests to achieve as
many true rejects as possible while controlling the mFDR.
Increasing the sample size capacity for each test to n∗j ≤ 10
enables cost-aware ERO to achieve the same power with
fewer tests. Releasing the restriction on sample size enables
cost-aware ERO to allocate the optimal number of samples
based on the prior of the null as well as the available budget
and the method returns an optimal n∗j . Appendix D shows

the comparisons for q = 0.1 and Appendix F shows comparisons with all of the other methods set to nj = 10. We
note, that the difference between restricting nj ≤ 100 and
not restricting nj is rather small. For most of the tests, the
sample sizes chosen are quite similar, but differences appear
when α-wealth becomes small, and the optimal sample size
without restriction is above 100.
It is worth noting that ERO and cost-aware ERO with nj = 1
are still quite different despite the restriction of sample size.
We can view the difference in performance between these
two methods as the benefit of allocating ϕj using the principle of indifference. The principle of indifference incorporates our prior knowledge of the probability of the null
hypothesis being true and aims to maintain α-wealth (as
a martingale). The experimental set up of (Aharoni and
Rosset, 2014) implicitly leverages similar prior knowledge
in the spending schemes proposed. All spending schemes
proposed in (Aharoni and Rosset, 2014) allow us to test at
least one true alternative, in expectation, at which point the
α-wealth should increase. This increase in α-wealth should
then sustain testing until another true alternative appears.
However, in the cost-aware ERO optimization problem, this
information is explicitly accounted for, and helps us avoid
situations described in 1 and 2. By restricting nj = 1,
we have effectively limited our ability to inflate ρj with a
large sample size, and influence Wα (j) towards being submartingale. On the other hand, the principle of indifference
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Figure 1: Empirical results for cost-aware ERO with random qj (a-c) and finite-horizon cost-aware ERO (d-f). Power,
mFDR, and median number of samples per test are shown in columns.
optimizes the two-player game to have a value of zero, by
limiting the size of ϕj , preventing the experimenter from experiencing α-death quickly, as seen in the constant spending
scheme.
Computation and Implementation In our experiments,
for one set of 1, 000 potential hypothesis tests ERO investing, cost-aware, and finite-horizon cost-aware ERO all
take ∼ 30 seconds on a single 2.5GHz core and 16Gb
RAM. The nonlinear optimization problem was solved using CONOPT (Drud, 1994). Because the solver depends
on initial values and heuristics to identify an initial feasible
point, infrequently the solver was not able to find a local
optimal solution; in these instances, the solver was restarted
10 times and if it failed on all restarts the iteration was discarded. Out of 10, 000 data sets at most 27 iterations were
discarded (for nj = 1). Code to replicate these experiments
is available at https://github.com/anonymous.
5.2

Random Prior of the Null Hypothesis

One of the benefits of incorporating a notion of sampling
cost into the hypothesis testing problem is the ability to
allocate resources based on the prior probability of the null,

q. We generated simulation data as previously described except the prior probability of the null hypothesis is selected at
random from qj ∼ Beta(a, b) where a + b = 100 and with
2, 500 independent realizations of the data. An upper limit
of 100 samples was set to all individual tests. Appendix B
contains pseudo-code and further implementation details.
Figure 1(a-c) shows the power, mFDR, and median number of samples per test as a function of E[qj ]. The results
show that cost-aware ERO α-investing achieves high power
while maintaining control of the mFDR. A key result of
this experiment is that should it not be possible to collect
as many samples as the principle of indifference yields, the
investigator may choose to not perform the test at all and
instead wait for a test (with associated prior) that does yield
an optimal sample size within the budget or may choose to
allow the α-wealth ante to adjust to the bound on the sample
size. This often occurs for large values of qj , which we
know by Theorem 2 will influence Wα (j) towards behaving
as a supermartingale. Cost-aware ERO will compensate by
increasing ρj through the sample size, nj , and will expend
the W$ available, as the optimization only considers a single
step.
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Figure 2: Cost-aware ERO investing and ERO investing for real gene expression data. Cost-aware ERO distributes the finite
allocation of samples across the set of genes while ERO expends the sample allocation within the first 20 tests.
5.3

Finite-Horizon Cost-aware ERO Investing

was performed with the optimal number of samples. This
procedure is compared to ERO investing with the maximum
number of samples for all tests that were selected to be performed by that procedure. For both procedures cj = 1, ∀j,
and W$ [0] = 1000. Pseudo-code and implementation details for this experiment can be found in Appendix B.

To test whether extending the horizon of the reward to be
maximized would enable better decisions as to (α, $)-wealth
allocation, we compared one-step and two-step ERO investing decision rules. Figure 1(d-f) shows two-step ERO has
high power for most values of E(qj ); for low values of E(qj )
the prior of all of the alternatives is so high that the method
chooses not to test. The finite horizon method uses a much
smaller sample size when it does test as evidenced by panels
(c) and (f) in Figure 1. Incorporating knowledge of the prior
probability of future tests into the decision rule enables it to
avoid a myopic optimization of the next reward and instead
allocate samples to a test that is likely to be more productive.
We expect that this hedging effect will continue as the finite horizon is extended beyond two-steps of the hypothesis
sequence.

Figure 2 shows a single iteration of the cost-aware and
ERO decision rules on the gene expression data set. The
ERO method selects many tests, but rapidly expends W$ ,
as it does not optimize the sample size. In contrast, costaware ERO is more conservative and tests when the benefits
outweigh the risks for a given dual-currency wealth state
(Wα , W$ ). Across 1000 permutations of the data cost-aware
ERO performed, on average, 32.9 tests and skipped 44.6
tests. For the tests that were performed, the average optimal
sample size was 26.9.

6

7

REAL DATA EXPERIMENTS

Gene expression data was collected to investigate the molecular determinant of prostate cancer (Dettling, 2004). The
data set contains 50 normal samples and 52 tumor samples
and each sample is a m = 6033 vector of gene expression levels. The data set has been normalized and logtransformed so that the data for each gene is roughly Gaussian. Let the empirical mean and standard deviation of the
normal samples be denoted µ̂j and σ̂j respectively. The goal
is to test whether the tumor gene expression is increased
relative to the normal samples.
A logistic function using only the first two samples for
each gene was used to compute the prior probability of the
−1
null hypothesis qj = 1 − (1 + exp(−β([x¯j ]1:2 − x0 ))) ,
where x0 = log10 (4)/σ and β = 2; these first two samples were then removed from the data set. The set of genes
was permuted randomly and the cost-aware decision function was computed for each gene in sequence with qj as
described and θ̄j = log10 (2)/σ̂j . If the optimal sample size
was greater than the number of available samples (n̄j = 50),
the test was skipped, otherwise the one-sided Gaussian test

DISCUSSION

We have introduced an ERO generalized α-investing procedure that has a self contained decision rule. This rule
removes the need for a user-specified allocation scheme and
optimally selects the sample size for each test. We have
shown empirical results in support of the benefits of optimizing these testing parameters rather than being left to user
choice. An experiment with gene expression data shows that
we can conduct more tests than with previous methods. The
societal impact and ethical concerns of this work are limited,
as this work proposes a principled method to control for
multiple testing. These concerns are influenced more by the
hypotheses and motivation by the experiment rather than
the multiple testing correction.
There are some limitations of the current work. First, the
cost-aware ERO method may be sensitive to misspecification in qj . Simulations with an increasing distance between
the true qj and that used by the cost-aware ERO method
show that cost-aware ERO performance degrades for misspecified values of qj (Appendix E), however, mFDR control is not affected.
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Second, the finite horizon method requires known values qj .
In a streaming situation this information may not be available. Finally, cost-aware ERO does not have a mechanism
to hedge the risk of dollar wealth or α-wealth expenditure.
In our simulations we observed that cost-aware ERO can
choose to ante (ϕj ) the entire pool of α-wealth on the first
promising test in the hopes of maximizing the expected reward. While this strategy is certainly one that maximizes
the expected reward, it may be too risky in practice. One
solution is to constrain ϕj for any single test or to include
ϕj in the objective function. Preliminary experiments on
including ϕj in the objective (Appendix F) are encouraging
for this direction. For future work, it would be interesting to
investigate a principled risk-hedging approach to conserve
some wealth for future tests with the hope that a test with a
more favorable reward structure is over the horizon.

Liang, K. and Nettleton, D. (2012). Adaptive and dynamic
adaptive procedures for false discovery rate control and
estimation. Journal of the Royal Statistical Society:
Series B (Statistical Methodology), 74(1):163–182.
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A

THEORETICAL ANALYSIS OF LONG-TERM ALPHA-WEALTH

A.1

Proof of Lemma 1

Proof of Lemma 1. The expected increment in α-wealth is
E[Wα (j) − Wα (j − 1)] = E[Rj ]α − E[1 − Rj ]

αj
.
1 − αj

This equation requires the probability of rejection, which can be written in factorized form as
Pr(Rj = 1) = Pr(Rj = 1|θj ∈ Hj ) Pr(θj ∈ Hj ) + Pr(Rj = 1|θj 6∈ Hj ) Pr(θj 6∈ Hj ).
Now, Pr(Rj = 1|θj ∈ Hj ) ≤ αj by Assumption 1 and Pr(Rj = 1|θj 6∈ Hj ) ≤ ρj by Assumption 2. Defining
Pr(θj ∈ Hj ) = qj gives the result.
A.2

Proof of Theorem 1

Proof. Since Θj = {0, θ̄j }, by lemma 1 we have
E [Wα (j) − Wα (j − 1) | Wα (j − 1)] = −



αj
αj
+ [ρj − (ρj − αj ) qj ] α +
1 − αj
1 − αj

We define Mj := ρj − (ρj − αj )qj , then {Wα (j) : j ∈ N} is submartingale, if and only if
Mj ≥

αj /(1 − αj )
.
α + αj /(1 − αj )

Since Mj = ρj − (ρj − αj )qj > ρj (1 − qj ), thus {Wα (j)} is submartingale if
αj /(1 − αj )
1
.
α + αj /(1 − αj ) 1 − qj

ρj ≥

A.3

Proof of Theorem 2

Proof. Let Mj := ρj − (ρj − αj )qj , by Lemma 1, {Wα (j) : j ∈ N} is supermartingale, if
Mj ≤

αj /(1 − αj )
.
α + αj /(1 − αj )

(20)

Next we define sj ∈ [0, (1 − αj )/αj ], a positive number to control how large the power is for the jth test, such that
ρj = sj αj /(1 − αj )
And we have
ρj − αj = [(sj − 1)αj + αj2 ]/(1 − αj ) ≥ (sj − 1)αj /(1 − αj ).
Thus,
Mj ≤

sj αj
(sj − 1)αj
−
qj .
1 − αj
1 − αj

The condition in (20) becomes
1 − αj
1
Mj ≤ sj − (sj − 1)qj = sj (1 − qj ) + qj ≤
.
αj
α + αj /(1 − αj )
Thus, for a given qj , the condition on sj for stochastically non-increasing wealth is


1
sj ≤
− qj /(1 − qj ).
α + αj /(1 − αj )

(21)
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The upper-bound in condition (21) is valid if it is positive. For j large enough, if αj /(1 − αj ) < α, then
1
1
− qj >
− qj .
α + αj /(1 − αj )
2α
If αj < 1/2, this term is positive and the upper-bound for sj is positive.
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B

SIMULATION DETAILS

In this section we describe simulations in greater detail so that our work can be fully reproduced. We briefly present the
cost-aware ERO α-investing method in algorithmic form.
Algorithm 1 Cost-aware ERO Algorithm
Input α, Wα (0), W$ (0)
j←0
while Wα (j) >  and W$ (j) >  do
Define qj , cj for hypothesis j
Solve Problem 18 to obtain ϕj , αj , ψj , and nj
Collect data (xj1 , . . . , xjnj ) and compute p-value pj .
if pj ≤ αj then
Rj ← 1
else
Rj ← 0
end if
Update W$ (j + 1) ← W$ (j) − cj nj
Update Wα (j + 1) ← Wα (j) − ϕj + Rj ψj
j ←j+1
end while

Experiment for Table 1 For cost-aware ERO, the initial value of αj was set 0.001, and the initial value of ρj was set
to 0.9. These initial values tended to give more conservative allocations of sample size as the optimal value of ρj often
approached a value of 1. In our simulation we define α = 0.05, Wα (0) = 0.0475, W$ (0) = 1000, niter = 10000 (number
of iterations), m = 1000 (maximum number of tests per iteration), and c = 1 (cost per sample). Wα (0) for implementations
of LORD and SAFFRON follow suggestions from (Javanmard and Montanari, 2018) and (Ramdas et al., 2018). An explicit
algorithm is given in Algorithm 2. A similar experimental set up is used for Table 2 and Table 4 where qj and nj are adjusted
respectively.
Experiment for Figure 1 We next discuss the experimental details for producing Figure 1. The initial value for ρj (and
for ρj+1 ) was set to 1. Contrary to the previous experiment, we desire to demonstrate that myopic allocation of samples
is avoided in finite-horizon ERO regardless of initial values. In our simulation we define α = 0.05, Wα (0) = 0.0475,
W$ (0) = 1e8, niter = 2500, m = 1000, and c = 1. An additional q, specifically q1001 is drawn for solving the finitehorizon optimization problem when we reach the final test. We sample qj from a Beta(a, 100 − a) distribution, and then
sample whether θj is null or not based on the realization of qj . This sampling scheme and relevant parameter values are
given in Algorithm 3.
Experiment for Figure 2 The real data experiment shown in Figure 2 and detailed in Section 6 can be broken down into
two steps: preprocessing and testing.
In preprocessing, we load in two dataframes, one containing gene expression data for 50 normal (non-cancerous) samples
(6033 × 50), and a second containing similar data for 52 tumor samples (6033 × 52). We take then mean across the normal
samples to obtain a (6033 × 1) vector containing the mean gene expression for normal patients. We calculate the standard
deviation in a similar manner and use these vectors to standardize the (6033 × 52) dataframe containing tumor samples.
Next, the first two columns of the tumor samples dataframe is separated from the remaining 50 columns to provide an
informed estimate of qj for each test. It is important to note that we are allowing the potential for misspecification of qj by
using an estimate of only two samples. Using these two samples:
−1

qj = 1 − (1 + exp(−β([x¯j ]1:2 − x0 )))

,

where x0 = log10 (4)/σ̂, β = 2, [x¯j ]1:2 denotes the sample mean of the two tumor samples separated from the remaining 50
tumor samples for the j th gene, and σ̂ is the estimated standard deviation from the normal samples.
During the testing process, we perform a random shuffle of the genes and then run testing. This process is shown in
Algorithm 4. In this scenario, we set α = 0.05, Wα (0) = 0.0475, W$ (0) = 1000, niter = 1000 (number of permutations),
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Algorithm 2 Simulation run in Table 1
Input α, Wα (0), W$ (0), niter , m, c
for i = 0 to i = niter do
Set seed to i
X =[]
for j = 0 to m do
Sample θj , with P r(θj = 0) = qj = 0.9, and P r(θj = 2) = 1 − qj = 0.1.
X[j] = 1000 realizations from N (θj , 1).
end for
for each testing method (unique row in Table 1) do
j←0
while Wα (j) >  and W$ (j) >  do
nj = 1
. Sample size to use if method not cost-aware.
if Spending and Investing rule separate then
Obtain ϕj from spending scheme.
Obtain αj , ψj from investing rule I
else
Obtain ϕj , αj , ψj from self-contained investing rule I. (If using cost-aware, obtain and update nj ).
end if
Perform 1-sided Z-test on X[j][0 : nj ], and obtain p-value, pj .
if pj ≤ αj then
Rj ← 1
else
Rj ← 0
end if
Update W$ (j + 1) ← W$ (j) − cnj
Update Wα (j + 1) ← Wα (j) − ϕj + Rj ψj
j ←j+1
end while
end for
end for
Aggregate results

Algorithm 3 Simulation run in Figure 1
Input α, Wα (0), W$ (0), niter , m, c
for i = 0 to i = niter do
Set seed to i
for a ∈ {10, 20, 30, 40, 50, 60, 70, 80, 90} do
X =[]
for j = 0 to m do
Sample qj ∼ Beta(a, 100 − a)
Sample θj , with P r(θj = 0) = qj , and P r(θj = 2) = 1 − qj .
X[j] = 1000 realizations from N (θj , 1).
end for
for each testing method (unique row in Figure 1) do
while Wα (j) >  and W$ (j) >  do
Perform while loop in Algorithm 2.
end while
end for
end for
end for
Aggregate results
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m = 6033, and c = 1. We set ERO investing to always use a sample size of nj = 50. For cost-aware ERO, we set the initial
value of ρj = 0.9 and do not set a restriction on the upper value of nj . However, if the optimized value is greater than 50, we
choose to skip the test. Lastly, we set the constraint of ϕj ≤ (1 − qj )Wα (j) to avoid quick α-death in some permutations.
This idea is supported by results seen in Table 5, where we do not allow all α-wealth to be myopically allocated to the next
test. We note that this does not affect tests with large qj very much, as one might expect, since those tests require small bets
in order to remain indifferent.
Algorithm 4 Simulation run in Figure 2
Input α, Wα (0), W$ (0), niter , m, c
for i = 0 to i = niter do
Set seed to i
Randomly shuffle data
for Method ∈ { ERO, cost-aware ERO} do
while Wα (j) >  and W$ (j) >  do
if Method is cost-aware ERO then
Set constraint ϕj ≤ (1 − qj )Wα (j)
Solve Problem 18 to obtain ϕj , αj , ψj , and nj
if 0 < nj ≤ 50 then
Perform test and update as per other simulations.
else
Skip test
end if
else
Perform test with sample size nj = 50 and update as per other simulations.
end if
end while
end for
end for
Aggregate results.
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C

EXTENSIONS OF COST-AWARE α-INVESTING

In this section, we explore extensions of cost-aware ERO α-investing.
Cost tradeoffs. In Problem 18 the monetary cost does not factor in to the objective except through the constraints. In
many practical applications, it may be useful to simultaneously maximize the α-reward and minimize the $-cost. In
those applications, the objective function can be augmented to E(Rj )ψj − γcj nj , where γ controls the trade-off between
improving α-wealth and minimizing $-cost.
Variable utility. Not all hypotheses may have equal value to the investigator and their value assessment may be independent
of their assessment of the prior probability of the null hypothesis (Ramdas et al., 2017). For example, an investigator may be
confident that a gene is differentially expressed in a particular tissue based on prior literature. Then the prior probability
that θj = 0 is low, pj ≈ 0, and the utility of testing that hypothesis is also low. There may be a different gene that has
not been reported to be differentially expressed in the tissue, but if it is it would be a major scientific discovery. Then,
the investigator may assign a high prior probability to the null θj = 0, but also a high utility to the event that the null is
rejected. A generalized form of the cost-aware decision rule can
be constructed to account for varying utility levels for
PK
each hypothesis in the batch by making the objective function j=1 Eθ (Rj )U (Rj )ψj , where U (Rj ) is the utility of the
rejection of the j-th null hypothesis.
Batch testing. Many biological experiments are conducted in batches. This scenario leads to a need for a decision rule that
provides (αj , ψj , nj )K
j=1 for a batch of K tests. To address this need, the objective function in Problem 18 can be modified
PK
to j=1 Eθ (Rj )ψj . It seems reasonable to expend all of the α-wealth for each batch and then collect the reward at the
PK
completion of the batch so that a next batch of hypotheses can be tested. Therefore, we have constraints j=1 ϕj ≤ Wα (0)
PK
and j=1 cj nj ≤ W$ (0). The other constraint remain and apply for each test in the batch.
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D

METHOD COMPARISON WITH q = 0.1

In Table 2 we explore the comparison of cost-aware ERO investing with other methods for qj = 0.1. The results presented in
the main body of the paper are for qj = 0.9 to align with previous work. When true alternatives are abundant, the principle
of indifference requires a large ante to remain indifferent. This causes cost-aware ERO to rapidly deplete the α-wealth. In
contrast, other methods do not increase the ante as severely as cost-aware ERO. However, it should be noted that the fraction
of the tests that are true rejects among those that are performed is very high. For example, in constant ERO investing the
proportion of true rejects is 24% and the proportion of true rejects for cost-aware ERO (nj ≤ 10) is 90%. This is a highly
desirable result for the setting of biological experiments and other settings where sample cost is nontrivial.
Tests

True Rejects

False Rejects

mFDR

α-spending
α-investing
α-rewards k = 1
α-rewards k = 1.1
ERO investing

10.0
932.4
925.0
926.5
934.3

2.49
231.55
230.13
221.54
230.87

0.00
0.46
0.46
0.42
0.45

0.001
0.002
0.002
0.002
0.002

relative

α-spending
α-investing
α-rewards k = 1
α-rewards k = 1.1
ERO investing

66.0
994.0
989.2
991.4
994.8

4.95
661.55
416.37
626.93
820.57

0.00
10.19
2.00
7.47
34.14

0.001
0.015
0.005
0.012
0.040

other

LORD++
LORD1
LORD2
LORD3
SAFFRON

885.8
1000.0
1000.0
1000.0
1000.0

197.07
93.81
301.45
271.22
779.92

0.39
0.07
0.94
0.68
23.92

0.002
0.001
0.004
0.003
0.030

cost-aware
cost-aware
cost-aware

ERO nj = 1
ERO nj ≤ 10
ERO n∗j

11.1
12.8
10.6

9.94
11.48
9.48

0.15
0.21
0.13

0.013
0.017
0.012

Scheme

Method

constant

Table 2: Comparison of cost-aware α-investing with state-of-the-art sequential hypothesis testing methods with a prior
probability of the null, q = 0.1 using 2,500 iterations. Cost-aware uses an initial ρj for each iteration of 1.
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E

SENSITIVITY ANALYSIS WITH RESPECT TO qj

Since the cost-aware ERO method makes use of the prior probability of the null hypothesis, qj , we investigate the sensitivity
of the method to misspecification of that parameter. Table 3 shows the number of tests, mean true rejects, mean false rejects,
and mFDR for simulation where the qj provided for optimization is misspecified. Specifically, we vary the specified qj ,
when holding the true qj fixed at 0.9. We performed 10, 000 iterations where cost-aware α-investing is restricted to a single
sample.
Tests

True Rejects

2.7
10.6
32.9
92.4
282.4
365.0

0.13
0.33
0.72
1.58
3.54
4.15

False Rejects

mFDR

0.06
0.06
0.08
0.13
0.20
0.22

0.049
0.047
0.047
0.049
0.044
0.041

Specified q
0.50
0.70
0.80
0.85
0.89
0.90

Table 3: Varying the magnitude of misspecification of qj shows that small deviations from the true value do not dramatically
change performance, however, larger misspecifications result in fewer tests performed and fewer rejections. However,
mFDR is still controlled.
When qj is fixed, the optimal sample size displays a peak. Empirically, it seems that when the probability of the null is large,
but not too large, cost-aware ERO finds it advantageous to commit a large amount of samples because the α-reward is high
if rejection is successful.

Figure 3: Optimal Sample size for varying levels of the prior of the null hypothesis. Here we initialize rhoj = 1, set
Wα = 0.0475, and do not set an upper bound for nj .
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F

COMPARISON WITH OTHER METHODS WITH nj = 10

The simulation study used in Table 1 was repeated with setting n = 10 for the existing methods and nj ≤ 10 for cost-aware
ERO. The cost per sample was set to cj = 1, and the total budget was W$ [0] = 1000. Hence, for methods that do not
optimize sample size, the number of tests was limited to 100.
Cost-aware ERO investing expends the pool to α-wealth more rapidly than other methods. The reason for this is that the
principle of indifference forces the ante for each experiment to be higher than it would otherwise be in ERO investing. The
overall power for cost-aware ERO is roughly the same as ERO investing and α-investing at 10% and the mFDR is controlled
at 0.05 for all methods.
Tests

True Rejects

False Rejects

mFDR

spending
investing
rewards k = 1
rewards k = 1.1
ERO investing

10.0
54.0
47.8
49.1
54.0

1.00
5.40
4.79
4.91
5.40

0.05
0.23
0.20
0.19
0.23

0.02
0.035
0.034
0.031
0.035

relative

spending
investing
rewards k = 1
rewards k = 1.1
ERO investing

66.0
99.9
99.9
99.9
99.9

6.55
10.00
10.00
10.00
10.00

0.05
0.52
0.45
0.40
0.52

0.006
0.045
0.039
0.036
0.045

cost-aware

ERO investing

39.8

3.99

0.21

0.040

other

LORD++
LORD1
LORD2
LORD3
saffron

98.0
100.0
100.0
100.0
100.0

9.80
9.99
10.00
10.00
10.00

0.12
0.07
0.16
0.16
0.44

0.011
0.006
0.014
0.014
0.038

Scheme

Method

constant

Table 4: Using a non-optimized pure strategy of setting n=10 (max n permissible in cost-aware simulations in Table 1).
Although using a larger number of samples for each test gives more powerful tests, the number of samples used by cost-aware
ERO investing is lower than all methods other than a constant spending scheme for α-spending, which only gives a single
true rejection.
In Table 4 it appears that cost-aware ERO performs fewer tests than standard ERO investing and has a lower number of
true rejects. However, the power is roughly the same and the mFDR is controlled in both methods. The reason for this
discrepancy is that cost-aware ERO expends the α-wealth via the ante while ERO maintains a pool of α-wealth because it
employs a relative ante allocation. We explored whether including the ante ϕj in the cost-aware objective would improve
the number of tests and true rejects. While this modification would not technically be an ERO method, it would be expected
to improve the conservation of α-wealth. Indeed, it does. Table 5 shows the comparisons with this additional term in the
objective.

Scheme

Method

relative
cost-aware

ERO investing
ERO investing

Tests

True Rejects

False Rejects

mFDR

139.3
176.1

13.15
16.20

0.24
0.16

0.016
0.009

Table 5: Using a strategy of setting n ≤ 10 (max n permissible in cost-aware simulations in Table 1). The addition of
−ϕj into the cost-aware objective enables cost-aware ERO to conserve α-wealth and perform more tests than relative ERO
investing. These mean value metrics were calculated with 10,000 data sets.
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TWO-STEP COST AWARE ERO INVESTING

In order to include the principle of indifference as a constraint in the two-step optimal procedure, the expected change in
α-wealth must be equal no matter what strategy the experimenter uses. It follows that the expected change in α-wealth must
be found for each strategy, and the system of equations solved.

Figure 4: Extensive form of two-step game between Investigator (Player I) and the Nature (Player II). Strategies for
each player are italicized. The leaves are labeled to denote the strategy taken by the investigator and are enumerated for
indifference equations.
In order for the minimax solution for the two-step game to hold, the following equations must hold.

0 = P (T T1 )(−ϕ1 − ϕ2 + ψ1 + ψ2 ) + P (T T2 )(−ϕ1 − ϕ2 + ψ1 )
+ P (T T3 )(−ϕ1 − ϕ2 + ψ2 ) + P (T T4 )(−ϕ1 − ϕ2 ) (22)
0 = P (T S1 )(−ϕ1 + ψ1 ) + P (T S2 )(−ϕ1 )

(23)

0 = P (ST1 )(−ϕ2 + ψ2 ) + P (ST2 )(−ϕ2 ),

(24)

P (T T1 ) = (q1 α1 + (1 − q1 )ρ1 )(q2 α2 + (1 − q2 )ρ2 )

(25)

P (T T2 ) = (q1 α1 + (1 − q1 )ρ1 )(q2 (1 − α2 ) + (1 − q2 )(1 − ρ2 ))

(26)

P (T T3 ) = (q1 (1 − α1 ) + (1 − q1 )(1 − ρ1 ))(q2 α2 + (1 − q2 )ρ2 )

(27)

P (T T4 ) = (q1 (1 − α1 ) + (1 − q1 )(1 − ρ1 ))(q2 (1 − α2 ) + (1 − q2 )(1 − ρ2 ))

(28)

where
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P (T S1 ) = q1 α1 + (1 − q1 )ρ1

(29)

P (T S2 ) = q1 (1 − α1 ) + (1 − q1 )(1 − ρ1 )

(30)

P (ST1 ) = q2 α2 + (1 − q2 )ρ2

(31)

P (ST2 ) = q2 (1 − α2 ) + (1 − q2 )(1 − ρ2 )

(32)

Selecting the optimal sample size of one step versus two steps reveals that knowledge of future tests inherently limits the
number of samples allocated on a single test. We can see that the knowledge of the second test greatly reduces the desire
to risk such high levels of alpha and dollar wealth. We do note, for certain combinations of q1 and q2 , although rare, the
optimized n1 and n2 seem to converge to large values and this may be due to the nonlinear solver.
q1 /q2

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9

0.588
0.608
0.591
0.851
1.895
553.624
518.789
15.839
49.216

0.588
0.588
0.588
0.851
1.895
552.578
514.956
14.104
13.400

0.595
0.594
0.588
0.851
1.895
550.467
1303.099
14.321
49.334

0.592
0.586
0.585
0.851
1.895
13.314
29.686
12.650
13.404

0.586
0.586
0.593
0.851
1.895
3264.044
13.409
12.650
13.612

0.458
0.587
0.586
0.851
1.895
12.280
12.350
12.962
13.038

0.532
0.485
0.484
0.851
1.895
12.383
12.536
12.473
12.958

0.765
0.767
1.603
1.613
1.895
12.107
12.510
12.530
12.969

0.352
0.351
0.434
0.851
1.895
12.790
13.653
13.660
13.498

Table 6: Values for optimal sample size of test 1, for unlimited W$ and Wα = 0.0475
q1 /q2

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9

0.473
0.582
0.595
0.589
0.554
0.506
0.528
0.487
0.508

0.473
0.473
0.473
0.591
0.556
0.506
0.526
0.466
0.508

0.434
0.434
0.474
0.434
0.434
0.506
0.543
0.465
0.507

0.851
0.851
0.851
0.851
0.851
0.851
0.851
0.851
0.851

1.895
1.895
1.895
1.895
1.895
1.895
1.895
1.895
1.895

522.703
12.704
13.037
12.225
11.828
12.271
11.963
12.379
12.092

12.334
13.577
13.584
12.700
12.252
12.723
12.462
12.653
12.964

14.206
14.201
20.383
48593.014
20.707
12.815
12.738
12.526
15.516

13.456
13.452
13.386
13.365
12.913
13.400
13.428
13.087
16.036

Table 7: Values for optimal sample size of test 2, for unlimited W$ and Wα = 0.0475

